Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas

Diabetes Educator

Volumn 35, Issue 4, 2009, Pages 631-640

  Vanschoonbeek, K ^a   Lansink, M ^b,c   van Laere, K M J ^b   Senden, J M G ^a   Verdijk, L B ^a   van Loon, L J C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c DANONE RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; BLOOD; CALORIC INTAKE; CARBOHYDRATE DIET; DIGESTION; ENTERIC FEEDING; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE; POSTPRANDIAL STATE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY FATS; DIGESTION; ENERGY INTAKE; ENTERAL NUTRITION; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; POSTMENOPAUSE; POSTPRANDIAL PERIOD;

EID: 69649086197     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721709335466     Document Type: Article

References (39)

1. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-986.
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:854-865.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:837-853.
5. Praet SF, Manders RJ, Meex RC, et al. Glycaemic instability is an underestimated problem in Type II diabetes. Clin Sci (Lond). 2006;111:119-126.
6. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycaemia mean? Diabet Med. 2004;21:208-213.
7. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes. 2005;54:1-7.
8. International Diabetes Federation. Guideline for management of postmeal glucose. www.idf.org. 2007;1-27.
9. Wolever TM, Gibbs AL, Mehling C, et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of lowglycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr. 2008;87:114-125.
10. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005;28:2267-2279.
11. Hofman Z, van Drunen JD, de Later C, Kuipers H. The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes. Eur J Clin Nutr. 2004;58:1553-1556.
12. Mann JI, De Leeuw I., Hermansen K., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis. 2004;14:373-394
13. Grysman A, Carlson T, Wolever TM. Effects of sucromalt on postprandial responses in human subjects. Eur J Clin Nutr. 2008;62(12):1364-1371.
14. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem. 1964;7:18-25.
15. Grupp U, Siebert G. Metabolism of hydrogenated palatinose, an equimolar mixture of alpha-D-glucopyranosido-1,6-sorbitol and alpha-D-glucopyranosido-1,6-mannitol. Res Exp Med (Berl). 1978;173:261-278.
16. Kawai K, Okuda Y, Yamashita K. Changes in blood glucose and insulin after an oral palatinose administration in normal subjects. Endocrinol Jpn. 1985;32:933-936.
17. Kawai K, Yoshikawa H, Murayama Y, Okuda Y, Yamashita K. Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm Metab Res. 1989;21:338-340.
18. MacDonald I. The bio-availability of isomaltulose in man and rat. Nutr Rep Intl. 1983;28:1083-1090.
19. Liao Z-H, Li Y-B, Yao B, Fan H-D, Hu G-L, Weng J-P. The effect of isomaltulose on blood glucose and lipids for diabetic subjects. Diabetes. 2001;50:A366.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
21. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care. 1995;18:245-250.
22. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26:881-885.
23. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care. 2002;25(suppl 1):S1-147.
24. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet. 1999;354:617-6121.
25. Tushuizen ME, Diamant M., Heine RJ Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes. Postgrad Med J. 2005;81:1-6.
26. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes-2006: a position statement of the American Diabetes Association. Diabetes Care. 2006;29:2140-2157.
27. Severijnen C, Abrahamse E, van der Beek EM, et al. Sterilization in a liquid of a specific starch makes it slowly digestible in vitro and low glycemic in rats. J Nutr. 2007;137:2202-2207.
28. Wolever TM, Jenkins DJA, Vuksan V, Katzman L, Jenkins AL, Josse RG. Variation in meal fat does not affect the relative blood glucose response of spaghetti in subjects with type 2 diabetes. Diabetes Nutr Metab. 1992;5:191-197.
29. Tsihlias EB, Gibbs AL, McBurney MI, Wolever TM. Comparison of high- and low-glycemic-index breakfast cereals with monounsaturated fat in the long-term dietary management of type 2 diabetes. Am J Clin Nutr. 2000;72:439-449.
30. Cohen JC, Noakes TD, Benade AJ. Serum triglyceride responses to fatty meals: effects of meal fat content. Am J Clin Nutr. 1988;47:825-827.
31. Hofman Z, Lansink M, Rouws C, De Van Drunen J, Kuipers H. Diabetes specific tube feed results in improved glycaemic and triglyceridaemic control during 6 h continuous feeding in diabetes patients. e-SPEN. 2007;2:44-50.
32. Gannon MC, Nuttall FQ, Lane JT, Burmeister LA. Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism. 1992;41: 1137-1145.
33. Gannon MC, Nuttall FQ, Neil BJ, Westphal SA. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism. 1988;37:1081-1088.
34. Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005;82:69-75.
35. Nuttall FQ, Mooradian AD, Gannon MC, Billington C, Krezowski P. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care. 1984;7: 465-470.
36. Manders RJ, Wagenmakers AJ, Koopman R, et al. Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am J Clin Nutr. 2005;82:76-83.
37. Tessari P, Kiwanuka E, Cristini M, et al. Slow versus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes. Diabetes Metab Res Rev. 2007;23(5):378-385.
38. Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr. 2004;80:1246-1253.
39. Higgins JA. Resistant starch: metabolic effects and potential health benefits. J AOAC Int. 2004;87:761-768.